Small molecule drug companies develop low-molecular-weight medicines designed to interact with specific biological targets. These compounds can often enter cells and may be formulated as oral or other conventional dosage forms across a wide range of therapeutic areas.
This category includes companies working on:
Browse 202 UK small molecule drug companies below.
In vitro skin penetration and dermal absorption contract research
An-eX Analytical Services is an independent contract research organisation specialising in in vitro dermal absorption and skin penetration science. The company provides human skin…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating…
Ion channel drug discovery platform for rare CNS disorders
Autifony Therapeutics is a clinical-stage UK biotech developing small molecule modulators of Kv3 voltage-gated potassium channels for rare genetic CNS disorders. Lead programmes…
Sustained-release ocular drug delivery for retinal disease
Re-Vana Therapeutics is a biotechnology company developing sustained-release drug delivery technologies for the treatment of serious retinal diseases. Its biodegradable hydrogel…
Contract development and manufacturing of complex small molecule APIs and ADCs
Sterling Pharma Solutions is a contract development and manufacturing organisation specialising in complex small molecule active pharmaceutical ingredient development and cGMP…
Anti-cancer drug formulation and manufacturing technology development services
PTC Oncology is a contract research organisation specialising in the formulation and manufacturing technology development of anti-cancer drugs. The company supports pharmaceutical…
Oncology biotech creation studio developing and spinning out cancer therapies
Cumulus Oncology is a company creation studio specialising in oncology drug discovery and development. The company identifies and sources novel cancer therapeutic assets from…
Clinical-stage company developing treatments for cancer cachexia and muscle wasting
Actimed Therapeutics is a clinical-stage specialty pharma developing treatments for cancer cachexia and muscle wasting disorders, areas with significant unmet need and no globally…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in…
Humanised transgenic mouse models for preclinical drug metabolism research
PhaSER Biomedical is a reagents and research tools company commercialising a transgenic mouse model for drug discovery and development applications. The mouse model is extensively…